Senate Bill Would Create New Diagnostics Center At FDA
This article was originally published in The Gray Sheet
Executive Summary
A bill under development by Sen. Orrin Hatch, R-Utah, would carve out a new center at FDA for regulating all advanced diagnostics, according to stakeholders familiar with recent versions of the draft legislation.
You may also be interested in...
Senators Circulate Plan For Stand-alone FDA Diagnostics Center, ‘In Vitro Clinical Test’ Rules
Senators are drafting legislation to create a stand-alone FDA Center to oversee diagnostics, including IVDs and LDTs, under a framework distinct from current medical device regulations.
Senators Circulate Plan For Standalone FDA Diagnostics Center, ‘In Vitro Clinical Test’ Rules
Senators are drafting legislation to create a standalone FDA Center to oversee diagnostics, including IVDs and LDTs, under a framework distinct from current medical device regulations.
CDRH In 2012: More Pilots, Guidances And Regs
The device center plans to finalize all the 510(k) program guidances it issued last year, among a boatload of 2012 priorities. Many of this year's top goals spring from the 510(k) and “science in regulatory decision making” reform programs that commanded attention in 2011.